Uric acid in hypertension and cardiovascular disease

M Alderman1

  • 1Albert Einstein College of Medicine, Bronx, NY, USA. alderman@aecom.yu.edu

Insights

High uric acid levels are linked to increased heart problems in treated hypertension patients. Further research is needed to determine if uric acid causes these cardiac events or is merely associated.

Area of Science:

  • Cardiology
  • Nephrology
  • Metabolic Diseases

Background:

  • Cardiovascular disease is the leading cause of death globally, with hypertension as a major risk factor.
  • Current antihypertensive therapies offer incomplete cardioprotection, necessitating novel risk identification strategies.
  • Elevated uric acid is increasingly recognized as a potential risk marker in various conditions, including hypertension.

Purpose of the Study:

  • To investigate the association between serum uric acid levels and cardiac morbidity and mortality in well-controlled hypertensive patients.
  • To determine if uric acid is an independent predictor of cardiac events beyond blood pressure reduction.

Main Methods:

  • Prospective study design.
  • Inclusion of a large cohort of well-controlled hypertensive subjects.
  • Analysis of the association between serum uric acid levels and cardiac events.

Main Results:

  • A strong, specific, stepwise, and independent association was found between increasing serum uric acid levels and cardiac morbidity and mortality.
  • This association persisted even in patients with effectively managed hypertension.

Conclusions:

  • Elevated serum uric acid is a significant predictor of cardiac events in treated hypertensive individuals.
  • Further investigation is required to elucidate the causal role of uric acid in the pathogenesis of cardiovascular disease.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...